Drug – bio-affecting and body treating compositions – Designated organic nonactive ingredient containing other... – Peptide containing
Patent
1988-07-22
1991-01-01
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic nonactive ingredient containing other...
Peptide containing
424 80, 424 81, 424435, 424 49, 560 47, 514536, 514944, 514950, 514900, 514901, 514902, 514969, 514777, 514779, 514781, 514782, 514784, A61K 9107, A61K 31195
Patent
active
049818759
ABSTRACT:
Etofenamate is used for the preparation of compositions useful in the treatment of bacterial, viral or fungicidal inflammations in the region of the oral cavity.
REFERENCES:
patent: 4623346 (1986-11-01), von Bittera et al.
patent: 4627852 (1986-12-01), von Bittera et al.
patent: 4746675 (1988-05-01), Makino et al.
patent: 4772470 (1988-09-01), Inoue et al.
patent: 4789667 (1988-12-01), Makino et al.
patent: 4871767 (1989-10-01), Beckermann et al.
The Merck Index, Tenth Edition, Published by Merck & Co., Inc., Rahway, N.J., 1983, p. 559, item 3824.
Chemical Abstracts, Band 76, Nr. 1, 3, Jan. 1972, Seite 31, Zusammenfassung Nr. 277q, Columbus, Ohio, U.S.; A. D. Inglot et al.
"Topical Treatment of Cutaneous Herpes Simplex in Humans with the Non--Steroid Antiinflammatory Drugs Mefenamic Acid and Indomethacim in Demethylsulfoxide", & Arch. Immunol. Ther. Exp., 1971 19 (4), 555-66, *Zusammenfassung, ins bensondere Formel I*.
Fischer Wolfgang
Heiss Rudiger
Leusner Bernd
Ohm Ulrich
Pelster Bernd
Bayer Aktiengesellschaft
Griffin Ronald W.
LandOfFree
Medicaments for the region of the oral cavity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicaments for the region of the oral cavity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicaments for the region of the oral cavity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1996565